Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Nov;76(5):406–411. doi: 10.1136/hrt.76.5.406

Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation.

A P Fitzpatrick 1, R J Lee 1, L M Epstein 1, M D Lesh 1, S Eisenberg 1, M M Sheinman 1
PMCID: PMC484570  PMID: 8963892

Abstract

OBJECTIVE: To define the value of tilt testing and hte additional yield of drug provocation over prolonged baseline tilt in different patient subgroups. (Many different protocols are in use for head-up tilt testing in heterogeneous groups of patients. Not all patients in reported series have recurrent syncope, and there is often a wide age range and a variable incidence of structural heart disease.) DESIGN: In a prospective study, baseline 60 degrees head-up tilt testing was undertaken for 45 minutes, initially without drug provocation. Patients who remained symptom free were given intravenous isoprenaline (isoproterenol) and further tilting or edrophonium (10 mg bolus) during tilt, in an order determined randomly before the start of the test. If they were symptom free after the first drug, they were given the other drug. A positive test was recorded when syncope or pre-syncope occurred with a rapid fall (> 30%) in blood pressure. The impact on tilt result of the type of symptoms, presence of significant structural heart disease (SHD), presence of a non-cardiovascular cause of sudden diminished consciousness (SDC), and age was then assessed by subgroup analysis. PATIENTS: 145 patients (73 female, mean age 51 (25), range 8-94) with one or more episodes of pre-syncope or syncope. RESULTS: 39 patients (27%, 21 female, age 49 (25) years) had positive tests and 106 (73%, 52 female, age 52 (25) years) negative tests. 27 (69%) had a positive test during baseline tilt at 20.5 (10.8) minutes, five (13%) with isoprenaline infusion, and seven (18%) with edrophonium bolus. Patients with recurrent syncope rather than single syncopal episodes or single or recurrent pre-syncope were more likely to have a positive tilt test (41% v 17%, P < 0.005) and patients with SHD or SDC (69/14 patients) were much less likely than patients without (16% v 42%, P < 0.0001). The yield of positive tests was similar if patients were below (26%) or above (27%) the mean age (50 years). When multiple factors were combined, the yield ranged from 0% for 21 patients under 50 years with SHD or SDC and without recurrent syncope to 73% in 11 patients over 50 years with recurrent syncope and no SHD or SDC. The additional yield in subgroups over 45 minute baseline tilt (70 (11)%) of isoprenaline (13 (10)%) was similar to that of edrophonium (17 (8)%, P = NS), but six (50% of those who were drug positive) patients required a second drug to produce a positive result (two with isoprenaline second, four with edrophonium second). CONCLUSIONS: Head-up tilt testing in a heterogeneous population has a low yield. Simple clinical characteristics define the type of patient who is likely to have a positive tilt test and the patient who is not and in whom other investigations should receive priority. The great majority of positive tests will occur during prolonged baseline testing if this is used. Isoprenaline and edrophonium produced similar additional yields of positive tests.

Full text

PDF
406

Images in this article

411Image
on p.411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abi-Samra F., Maloney J. D., Fouad-Tarazi F. M., Castle L. W. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. Pacing Clin Electrophysiol. 1988 Aug;11(8):1202–1214. doi: 10.1111/j.1540-8159.1988.tb03973.x. [DOI] [PubMed] [Google Scholar]
  2. Almquist A., Goldenberg I. F., Milstein S., Chen M. Y., Chen X. C., Hansen R., Gornick C. C., Benditt D. G. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 1989 Feb 9;320(6):346–351. doi: 10.1056/NEJM198902093200603. [DOI] [PubMed] [Google Scholar]
  3. Fitzpatrick A., Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet. 1989 Mar 25;1(8639):658–660. doi: 10.1016/s0140-6736(89)92155-7. [DOI] [PubMed] [Google Scholar]
  4. Grubb B. P., Temesy-Armos P., Hahn H., Elliott L. Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin. Am J Med. 1991 Jan;90(1):6–10. doi: 10.1016/0002-9343(91)90499-n. [DOI] [PubMed] [Google Scholar]
  5. Kapoor W. N., Brant N. Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Intern Med. 1992 Mar 1;116(5):358–363. doi: 10.7326/0003-4819-116-5-358. [DOI] [PubMed] [Google Scholar]
  6. Kenny R. A., Ingram A., Bayliss J., Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet. 1986 Jun 14;1(8494):1352–1355. doi: 10.1016/s0140-6736(86)91665-x. [DOI] [PubMed] [Google Scholar]
  7. Lurie K. G., Dutton J., Mangat R., Newman D., Eisenberg S., Scheinman M. Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing. Am J Cardiol. 1993 Dec 1;72(17):1286–1290. doi: 10.1016/0002-9149(93)90298-q. [DOI] [PubMed] [Google Scholar]
  8. Pongiglione G., Fish F. A., Strasburger J. F., Benson D. W., Jr Heart rate and blood pressure response to upright tilt in young patients with unexplained syncope. J Am Coll Cardiol. 1990 Jul;16(1):165–170. doi: 10.1016/0735-1097(90)90474-4. [DOI] [PubMed] [Google Scholar]
  9. Raviele A., Gasparini G., Di Pede F., Delise P., Bonso A., Piccolo E. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol. 1990 Jun 1;65(20):1322–1327. doi: 10.1016/0002-9149(90)91321-v. [DOI] [PubMed] [Google Scholar]
  10. Raviele A., Gasparini G., Di Pede F., Menozzi C., Brignole M., Dinelli M., Alboni P., Piccolo E. Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J. 1994 Jan;127(1):103–111. doi: 10.1016/0002-8703(94)90515-0. [DOI] [PubMed] [Google Scholar]
  11. Sheldon R. Evaluation of a single-stage isoproterenol-tilt table test in patients with syncope. J Am Coll Cardiol. 1993 Jul;22(1):114–118. doi: 10.1016/0735-1097(93)90824-k. [DOI] [PubMed] [Google Scholar]
  12. Sheldon R., Killam S. Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol. 1992 Mar 15;19(4):773–779. doi: 10.1016/0735-1097(92)90517-q. [DOI] [PubMed] [Google Scholar]
  13. Stevens P. M. Cardiovascular dynamics during orthostasis and the influence of intravascular instrumentation. Am J Cardiol. 1966 Feb;17(2):211–218. doi: 10.1016/0002-9149(66)90354-7. [DOI] [PubMed] [Google Scholar]
  14. Waxman M. B., Yao L., Cameron D. A., Wald R. W., Roseman J. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons. Am J Cardiol. 1989 Jan 1;63(1):58–65. doi: 10.1016/0002-9149(89)91076-x. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES